IL37 and lung cancer: In contrast, research by Kim et al. (2019) demonstrated that autophagy inhibition counteracted the antifibrotic effects of IL-37 in lung cancer, highlighting autophagy’s significant contribution to IL-37’s antifibrotic impact in bleomycin-induced lung damage (Kim et al. 2019).